MYC and neuroblastoma: Our discovery of c-MYC mediating resistance to 13-cisRA and being highly expressed in PD neuroblastoma suggests that MYC transcriptional activation occurs both in a subset of patients at diagnosis and likely more frequently in tumors at time of PD.